| Total | Males | Females | Test statistic | pa | Effect size (CI 95%) | |||
---|---|---|---|---|---|---|---|---|---|
Mean (SD) | Above cutoff | Mean (SD) | Above cutoff | Mean (SD) | Above cutoff | ||||
Standardized tools | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 PHQ-9 | 9.43 (6.51) | 42.8% | 6.93 (5.62) | 27.3% | 10.72 (6.49) | 51.0% | Ust = −24.70 |  < 0.001 | 0.35b (0.33–0.38) |
 GAD-7 | 9.54 (5.86) | 41.8% | 6.94 (5.28) | 27.6% | 10.96 (5.63) | 57.3% | Ust = −28.26 |  < 0.001 | 0.41b (0.38–0.43) |
 PHQ-15 | 8.15 (5.85) | 34.6% | 5.33 (4.63) | 14.8% | 9.66 (5.83) | 45.1% | Ust = −31.79 |  < 0.001 | 0.46b (0.43–0.48) |
 PROMIS (T-score) | 52.50 (12.57) | 46.8% | 48.32 (12.02) | 28.0% | 54.76 (12.21) | 49.3% | Ust = −20.93 |  < 0.001 | 0.30b (0.27–0.33) |
 Fear of COVID-19 | 14.80 (5.04) |  | 13.14 (4.59) | – | 15.75 (5.03) | – | Ust = −21.51 |  < 0.001 | 0.31b (0.28–.33) |
 UCLA | 20.69 (13.93) |  | 17.42 (13.26) | – | 22.32 (13.89) | – | Ust = −14.92 |  < 0.001 | 0.21b (0.19–0.24) |
 CD-RISC-10 | 17.79 (8.28) |  | 20.12 (8.15) | – | 16.57 (8.00) | – | Ust = 17.48 |  < 0.001 | 0.25b (0.22–0.28) |
 PTGI-SF | 20.95 (10.68) |  | 18.49 (10.79) | – | 22.49 (10.25) | – | Ust = −14.92 |  < 0.001 | 0.21b (0.19–0.24) |
 | Yes (%) | No (%) | Yes (%) | No (%) | Yes (%) | No (%) |  | Pc |  |
DSM5 Cross-Cutting -Sleep problemsSymptoms | 32.3 | 67.7 | 22.2 | 77.8 | 37.6 | 62.4 | χ2 = 176.03 |  < 0.001 | 0.16d (0.14–1) |
Risky behaviorse | Yes (%) | No (%) | Yes (%) | No (%) | Yes (%) | No (%) | Â | Pc | Â |
 Self-harm | 28.4 | 71.4 | 22.8 | 77.2 | 31.9 | 68.1 | χ2 = 64.57 |  < 0.001 | 0.10d (0.08–1) |
 Binge eating | 37.3 | 62.7 | 30.4 | 69.6 | 41.3 | 58.7 | χ2 = 81.83 |  < 0.001 | 0.11d (0.09–1) |
 Reckless driving | 20.9 | 79.1 | 32.5 | 67.5 | 14.4 | 85.6 | χ2 = 319.68 |  < 0.001 | 0.21d (0.19–1) |
 Binge drinking | 42.2 | 57.8 | 44.0 | 56.0 | 41.2 | 58.8 | χ2 = 5.29 | 0.21 | 0.03d (0–1) |
 Cannabis use | 7.5 | 92.5 | 10.1 | 89.9 | 6.1 | 93.9 | χ2 = 38.33 |  < 0.001 | 0.07d (0.05–1) |